Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedules
Crossref DOI link: https://doi.org/10.1007/s00280-014-2655-x
Published Online: 2014-12-23
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hamberg, P.
Mathijssen, R. H. J.
de Bruijn, P.
Leonowens, C.
van der Biessen, D.
Eskens, F. A. L. M.
Sleijfer, S.
Verweij, J.
de Jonge, M. J. A.
Text and Data Mining valid from 2014-12-23